Long-term safety and efficacy of stiripentol for the treatment of Dravet syndrome: A multicenter, open-label study in Japan

Independent Judgment Committee whoprovided guidance, STP-1 Study Group

Research output: Contribution to journalArticlepeer-review

37 Citations (Scopus)

Fingerprint Dive into the research topics of 'Long-term safety and efficacy of stiripentol for the treatment of Dravet syndrome: A multicenter, open-label study in Japan'. Together they form a unique fingerprint.

Medicine & Life Sciences